Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
R. J. Head, M. F. Fay, L. Cosgrove, K. Y. C. Fung, D. Rundle-Thiele & J. H. Martin. (2017) Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma. Cancer Biology & Therapy 18:12, pages 917-926.
Read now
Read now
Articles from other publishers (53)
Ruixuan Wang, Yanhong Chen, Weilu Kuang, Wuzhong Jiang, Wenjing Zeng, Yinyun Chen & Zhengzheng Liu. (2023) Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Gianfranco Natale, Elisabetta Fini, Pasquale Fabio Calabrò, Marco Carli, Marco Scarselli & Guido Bocci. (2023) Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?. Cancer Letters 560, pages 216125.
Crossref
Crossref
Pavel Burko, Giuseppa D’Amico, Ilia Miltykh, Federica Scalia, Everly Conway de Macario, Alberto J. L. Macario, Giuseppe Giglia, Francesco Cappello & Celeste Caruso Bavisotto. (2023) Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?. International Journal of Molecular Sciences 24:5, pages 4883.
Crossref
Crossref
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu & Xin-Ying Ji. (2023) Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 28:3, pages 1283.
Crossref
Crossref
Jessica K Sullivan, Paul P Fahey, Kinglsey E Agho, Simon P Hurley, Zhihui Feng, Richard O Day & David Lim. (2023) Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis. Neuro-Oncology Practice 10:1, pages 13-23.
Crossref
Crossref
Subrata Das, Anupam Das Talukdar, Deepa Nath & Manabendra Dutta Choudhury. 2023. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy. Computational Methods in Drug Discovery and Repurposing for Cancer Therapy
19
41
.
Anna-Maria Barciszewska, Agnieszka Belter, Iwona Gawrońska, Małgorzata Giel-Pietraszuk & Mirosława Z. Naskręt-Barciszewska. (2022) Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines. Frontiers in Oncology 12.
Crossref
Crossref
Shafina Siddiqui, Ankita Jaywant Deshmukh, Priyanka Mudaliar, Apoorva Jagannath Nalawade, Deepak Iyer & Jyotirmoi Aich. (2022) Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review. Journal of the Egyptian National Cancer Institute 34:1.
Crossref
Crossref
Eligija Damanskienė, Ingrida Balnytė, Angelija Valančiūtė, Marta Marija Alonso & Donatas Stakišaitis. (2022) Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy. Biomedicines 10:5, pages 968.
Crossref
Crossref
Fangting You, Caiyi Zhang, Xiaoxiao Liu, Daofei Ji, Tong Zhang, Rutong Yu & Shangfeng Gao. (2021) Drug repositioning: Using psychotropic drugs for the treatment of glioma. Cancer Letters.
Crossref
Crossref
Guochao Liu, David Lim, Zuchao Cai, Wenwen Ding, Zhujun Tian, Chao Dong, Fengmei Zhang, Gongshe Guo, Xiaowei Wang, Pingkun Zhou & Zhihui Feng. (2021) The Valproate Mediates Radio-Bidirectional Regulation Through RFWD3-Dependent Ubiquitination on Rad51. Frontiers in Oncology 11.
Crossref
Crossref
Taciani de Almeida Magalhães, Graziella Ribeiro de Sousa, Gustavo Alencastro Veiga Cruzeiro, Luiz Gonzaga Tone, Elvis Terci Valera & Kleiton Silva Borges. (2020) The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology. Journal of Molecular Medicine 98:4, pages 495-512.
Crossref
Crossref
Wei Han, Fan Yu, Jiachao Cao, Bo Dong, Wei Guan & Jia Shi. (2020) Valproic Acid Enhanced Apoptosis by Promoting Autophagy Via Akt/mTOR Signaling in Glioma. Cell Transplantation 29, pages 096368972098187.
Crossref
Crossref
M.Pilar Bayona-Bafaluy, Olivia Esteban, Javier Ascaso, Julio Montoya & Eduardo Ruiz-Pesini. (2019) Oxidative phosphorylation inducers fight pathological angiogenesis. Drug Discovery Today 24:9, pages 1731-1734.
Crossref
Crossref
Saranya Tongpan, Wannisa Sukhorum, Supatcharee Arun, Tarinee Sawatphanich & Sitthichai Iamsaard. (2019) Valproic acid changes the expression of tyrosine‐phosphorylated proteins in rat seminal vesicle. Andrologia 51:7.
Crossref
Crossref
Diana A.R. Julie, Zartaj Ahmed, Stephen C. Karceski, Susan C. Pannullo, Theodore H. Schwartz, Bhupesh Parashar & A. Gabriella Wernicke. (2019) An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy. Seizure 70, pages 30-37.
Crossref
Crossref
Sharon Berendsen, Elselien Frijlink, Jèrôme Kroonen, Wim G M Spliet, Wim van Hecke, Tatjana Seute, Tom J Snijders & Pierre A Robe. (2019) Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples. Neuro-Oncology Advances 1:1.
Crossref
Crossref
Cláudia Braga, Ana R. Vaz, M. Conceição Oliveira, M. Matilde Marques, Rui Moreira, Dora Brites & Maria J. Perry. (2019) Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability. European Journal of Medicinal Chemistry.
Crossref
Crossref
Rashmi R. Shah & Peter D. Stonier. (2019) Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead. Journal of Clinical Pharmacy and Therapeutics 44:1, pages 6-22.
Crossref
Crossref
Marta Maschio & Francesco Paladin. 2019. Oligodendroglioma. Oligodendroglioma
43
54
.
Iwona Anna Ciechomska, Marta Patrycja Marciniak, Judyta Jackl & Bozena Kaminska. (2018) Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide. Frontiers in Pharmacology 9.
Crossref
Crossref
Victor M. Lu, Pavlos Texakalidis, Kerrie L. McDonald, Rania A. Mekary & Timothy R. Smith. (2018) The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis. Clinical Neurology and Neurosurgery 174, pages 149-155.
Crossref
Crossref
Yan-Hong Chen, Wen-jing Zeng, Zhi-peng Wen, Quan Cheng & Xiao-Ping Chen. (2018) Under explored epigenetic modulators: role in glioma chemotherapy. European Journal of Pharmacology 833, pages 201-209.
Crossref
Crossref
Jing Huang, Danwei Zhao, Zhixiong Liu & Fangkun Liu. (2018) Repurposing psychiatric drugs as anti-cancer agents. Cancer Letters 419, pages 257-265.
Crossref
Crossref
Karen L. Fink & Anand K. Deo. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
45
58
.
Ambra Rizzo, Sara Donzelli, Vita Girgenti, Andrea Sacconi, Chiara Vasco, Andrea Salmaggi, Giovanni Blandino, Marta Maschio & Emilio Ciusani. (2017) In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Sitthichai Iamsaard, Wannisa Sukhorum, Supatcharee Arun, Nichapa Phunchago, Nongnuch Uabundit, Porntip Boonruangsri & Malivalaya Namking. (2017) Valproic acid induces histologic changes and decreases androgen receptor levels of testis and epididymis in rats. International Journal of Reproductive BioMedicine 15:4, pages 217-224.
Crossref
Crossref
Siwei Liu, Bilin Liang, Huiting Jia, Yuhan Jiao, Zhongqiu Pang & Yongye Huang. (2017) Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. FEBS Open Bio 7:6, pages 798-810.
Crossref
Crossref
Dovilė Kavaliauskaitė, Donatas Stakišaitis, Justė Martinkutė, Lina Šlekienė, Arūnas Kazlauskas, Ingrida Balnytė, Vaiva Lesauskaitė & Angelija Valančiūtė. (2017) The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression. BioMed Research International 2017, pages 1-12.
Crossref
Crossref
Wannisa Sukhorum & Sitthichai Iamsaard. (2017) Changes in testicular function proteins and sperm acrosome status in rats treated with valproic acid. Reproduction, Fertility and Development 29:8, pages 1585.
Crossref
Crossref
Ina Patties, Rolf-Dieter Kortmann, Franziska Menzel & Annegret Glasow. (2016) Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Supriya Mallick, Rony Benson, Abdul Hakim & Goura K. Rath. (2016) Management of glioblastoma after recurrence: A changing paradigm. Journal of the Egyptian National Cancer Institute 28:4, pages 199-210.
Crossref
Crossref
Kristin M. Knudsen-Baas, Anders Engeland, Nils Erik Gilhus, Anette M. Storstein & Jone F. Owe. (2016) Does the choice of antiepileptic drug affect survival in glioblastoma patients?. Journal of Neuro-Oncology 129:3, pages 461-469.
Crossref
Crossref
Yi-Chao Hsu, Chien-Yu Kao, Yu-Fen Chung, Don-Ching Lee, Jen-Wei Liu & Ing-Ming Chiu. (2016) Activation of Aurora A kinase through the FGF1/FGFR signaling axis sustains the stem cell characteristics of glioblastoma cells. Experimental Cell Research 344:2, pages 153-166.
Crossref
Crossref
Sharon Berendsen, Meri Varkila, Jérôme Kroonen, Tatjana Seute, Tom J. Snijders, Frans Kauw, Wim G.M. Spliet, Marie Willems, Christophe Poulet, Marike L. Broekman, Vincent Bours & Pierre A. Robe. (2016) Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro-Oncology 18:5, pages 700-706.
Crossref
Crossref
Roberta Rudà, Alessia Pellerino & Riccardo Soffietti. (2016) Does valproic acid affect tumor growth and improve survival in glioblastomas?. CNS Oncology 5:2, pages 51-53.
Crossref
Crossref
Li-Fong Seet, Li Zhen Toh, Sharon N. Finger, Stephanie W. L. Chu, Branko Stefanovic & Tina T. Wong. (2015) Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis. Journal of Molecular Medicine 94:3, pages 321-334.
Crossref
Crossref
JIN-KU LEE, DO-HYUN NAM & JEONGWU LEE. (2016) Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges. Oncology Letters 11:2, pages 1281-1286.
Crossref
Crossref
H. A. Gefroh-Grimes & B. E. Gidal. (2016) Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics. Acta Neurologica Scandinavica 133:1, pages 4-16.
Crossref
Crossref
P. Icard, T. Vallantin, P. Kafara, J. -M. Steyaert, L. Schwartz & H. Lincet. (2015) Baisse du citrate dans la cellule tumorale : une jauge à remettre à niveau ?The decrease of citrate in tumor cells: a gauge to upgrade?. Oncologie 17:7-8, pages 315-320.
Crossref
Crossref
Marta Mellai, Monica Cattaneo, Alessandra Maria Storaci, Laura Annovazzi, Paola Cassoni, Antonio Melcarne, Pasquale De Blasio, Davide Schiffer & Ida Biunno. (2015)
SEL1L
SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
. Oncotarget 6:14, pages 12452-12467.
Crossref
Crossref
Zhiqi Song, Deming Zhao, Huajia Zhao & Lifeng Yang. (2014) NRSF: an Angel or a Devil in Neurogenesis and Neurological Diseases. Journal of Molecular Neuroscience 56:1, pages 131-144.
Crossref
Crossref
Mehmet Asim Bilen, Siqing Fu, Gerald S. Falchook, Chaan S. Ng, Jennifer J. Wheler, Maen Abdelrahim, Basak Erguvan-Dogan, David S. Hong, Apostolia M. Tsimberidou, Razelle Kurzrock & Aung Naing. (2015) Phase I trial of valproic acid and lenalidomide in patients with advanced cancer. Cancer Chemotherapy and Pharmacology 75:4, pages 869-874.
Crossref
Crossref
G. Huberfeld & J. Pallud. (2015) L’épilepsie associée aux tumeurs cérébrales. Pratique Neurologique - FMC 6:1, pages 19-33.
Crossref
Crossref
Yang Yuan, Wang Xiang, Mao Qing, Liu Yanhui, Luo Jiewen & Mao Yunhe. (2014) Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review. Seizure 23:10, pages 830-835.
Crossref
Crossref
Felipe de Almeida Sassi, Lílian Caesar, Mariane Jaeger, Carolina Nör, Ana Lucia Abujamra, Gilberto Schwartsmann, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Patrícia Luciana da Costa Lopez & Rafael Roesler. (2014) Inhibitory Activities of Trichostatin A in U87 Glioblastoma Cells and Tumorsphere-Derived Cells. Journal of Molecular Neuroscience 54:1, pages 27-40.
Crossref
Crossref
Vera Riehmer, Jens Gietzelt, Ulrike Beyer, Bettina Hentschel, Manfred Westphal, Gabriele Schackert, Michael C. Sabel, Bernhard Radlwimmer, Torsten Pietsch, Guido Reifenberger, Michael Weller, Ruthild G. Weber & Markus Loeffler. (2014)
Genomic profiling reveals distinctive molecular relapse patterns in
IDH1/2
wild-type glioblastoma
. Genes, Chromosomes and Cancer 53:7, pages 589-605.
Crossref
Crossref
Feng-qiang Yang, Min Liu, Feng-ping Yang, Jianping Che, Wei Li, Wei Zhai, Guang-chun Wang, Jun-hua Zheng & Xi Li. (2014) VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α. Molecular Biology Reports 41:3, pages 1511-1518.
Crossref
Crossref
Marta Maleszewska, Aleksandra Steranka & Bozena Kaminska. (2014) The effects of selected inhibitors of histone modifying enzyme on C6 glioma cells. Pharmacological Reports 66:1, pages 107-113.
Crossref
Crossref
Irfan A. Qureshi & Mark F. Mehler. (2013) Developing epigenetic diagnostics and therapeutics for brain disorders. Trends in Molecular Medicine 19:12, pages 732-741.
Crossref
Crossref
Marta Maleszewska & Bozena Kaminska. (2013) Is Glioblastoma an Epigenetic Malignancy?. Cancers 5:4, pages 1120-1139.
Crossref
Crossref
Sara Negrini, Ilaria Prada, Rosalba D’Alessandro & Jacopo Meldolesi. (2013) REST: an oncogene or a tumor suppressor?. Trends in Cell Biology 23:6, pages 289-295.
Crossref
Crossref
Bilegtsaikhan Tsolmongyn, Naoki Koide, Erdenezaya Odkhuu, Abedul Haque, Yoshikazu Naiki, Takayuki Komatsu, Tomoaki Yoshida & Takashi Yokochi. (2013) Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation. Cellular Immunology 282:2, pages 100-105.
Crossref
Crossref